Viewing Study NCT00857259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2026-01-04 @ 2:01 PM
Study NCT ID: NCT00857259
Status: TERMINATED
Last Update Posted: 2011-08-19
First Post: 2009-03-04
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Choroidal Neo-Vascular Age-onset Macular Degeneration View
None Age-related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AMD View
None macular degeneration View
None Everolimus View
None Lucentis View
None Ranibizumab View
None Choroidal Neo-Vascular (CNV) age-onset macular degeneration View
None Age-related Macular Degeneration (AMD) View